A two-week-old baby is referred to the Red Cross War Memorial Children's Hospital in Cape Town. The infant, who was born ...

Long-acting injectable antiretroviral therapy (ART) can be administered at home to persons living with HIV as safely and ...

Only 6.9% of people with drug-resistant infections in eight large, low- and middle-income countries received an appropriate ...

Real-world data indicated ART with DTG+3TC was effective and well tolerated among patients with HIV infection regardless of prior ART exposure.

Tackling HIV continues to be a major public health challenge, mainly because the persistence of viral reservoirs means that ...

Dolutegravir is recommended by the World Health Organization (WHO) for infants, children and adults and is the preferred HIV ...

In a first-ever milestone, Africa’s initial HIV cure trial has yielded historic findings: 20% of patients have remained off ...

An ambitious plan to stop the global threat of AIDS has been derailed. But many are hopeful that progress can be salvaged.

Research on HIV prevention among trans people was already scarce, but Trump's restructuring of the health agency decimates ...

President Trump’s first 100 days has roiled health and science as part of the administration’s plan to reshape the federal ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...